A study to describe the experience of patients with metastatic hormone sensitive prostate cancer being treated with androgen receptor pathway inhibitor
Study description
A multicentric, retrospective, non-interventional, cohort study to compare the safety and use of androgen receptor pathway inhibitors in men with metastatic hormone-sensitive prostate cancer using data from remote monitoring and medical files.
Key results
Interim analysis: 337 eligible • analysis ongoing
